Close Menu

NIH

The seven technologies feature different methods, including CRISPR and microfluidics, and can be performed in many settings and with a variety of sample types.

A consortium convened by Friends of Cancer Research has made progress in quantifying sources of TMB assay discordance and created a new test-alignment software tool.

The forum will gather information on issues surrounding SARS-CoV-2 testing and diagnostics from federal officials and the private sector.

Tasso said academic medical institutions, government agencies, cancer centers, and pharma organizations are already using its blood collection devices.

The firm's test detects DNA from tick-borne bacteria directly from a patient's blood, and clinical studies are planned for the 2021 tick season.

The test was selected for accelerated development and commercialization support by the NIH through the RADx Tech program for COVID-19 diagnostics.

A research team said the study provides some evidence that there is potential for saliva testing in broad surveillance of past exposure to SARS-CoV-2.

News items for the in vitro diagnostics industry for the week of June 15, 2020.

The new funding opportunities come as part of the NIH's Rapid Acceleration of Diagnostics program, which aims to support SARS-CoV-2 testing technologies. 

In December the firm won $4 million from CARB-X to support the platform's first test identifying the most common bloodstream infections associated with sepsis.

Pages